Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why J&J Is Poised to Outperform

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.

What: Shares of Johnson & Johnson (NYSE: JNJ  ) climbed nearly 2% today after Goldman Sachs upgraded the health-care giant from sell, to neutral.

So what: Along with the upgrade, analyst Jami Rubin boosted his price target on the stock to $95 (from $87), representing about 8% worth of upside to yesterday's close. J&J shares have slumped in recent months on slowing growth at its largest unit, medical devices and diagnostics, but Rubin believes that continued strength from the pharmaceuticals side could help fuel a comeback over the next 12 months.

Now what: Goldman now expects J&J to post EPS of $1.32 in Q3, and $5.48 for 2013, up slightly from its prior view thanks to the company's steady stream of new drug launches. "No company depicts this transformation better than JNJ's pharma business, in our view," noted Goldman. "With 70% of current sales leveraged to specialty/biologics and with most of JNJ's pipeline assets following the same pattern, we expect product mix to continue moving closer to biotech." When you couple those prospects with the stock's forward P/E of 15 and 3%-plus dividend yield, J&J's risk/reward trade-off really does look appealing. 

More compelling income opportunities
Dividend stocks can make you rich. It's as simple as that. While they don't garner the notoriety of high-flying growth stocks, they're also less likely to crash and burn. And over the long term, the compounding effect of the quarterly payouts, as well as their growth, adds up faster than most investors imagine. With this in mind, our analysts sat down to identify the absolute best of the best when it comes to rock-solid dividend stocks, drawing up a list in this free report of nine that fit the bill. To discover the identities of these companies before the rest of the market catches on, you can download this valuable free report by simply clicking here now.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2679445, ~/Articles/ArticleHandler.aspx, 9/28/2016 10:20:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,268.84 40.54 0.22%
S&P 500 2,161.35 1.42 0.07%
NASD 5,314.54 8.83 0.17%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 10:05 AM
JNJ $118.88 Down -0.34 -0.29%
Johnson and Johnso… CAPS Rating: *****